Survey on the SARS-CoV-2 serum antibody retention and health condition both before and after the SARS-CoV-2 vaccine introduction

Survey on the SARS-CoV-2 serum antibody retention and health condition both before and after the SARS-CoV-2 vaccine introduction, and long-term transiotion of the SARS-CoV-2 serum antibody titer. - COVID-19, SARS-CoV-2 serum antibody tier, SARS-CoV-2 vaccine

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1061200057

Enrollment

2500

Registered

2021-02-19

Start date

2021-02-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 infection

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: School staff who wish to be vaccinated against the SARS-CoV-2 School staff who have agreed to participate in this study

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Transition of SARS-CoV-2 serum antibody titer both before and after the SARS-CoV-2 vaccine introduction	—

Secondary

Measure	Time frame
Retention status of SARS-CoV-2 serum antibody before the SARS-CoV-2 vaccine introduction. Health condition after the SARS-CoV-2 vaccine introduction	—

Contacts

Public ContactShin Ohira

Kawasaki Medical School Hospital

ohira@med.kawasaki-m.ac.jp+81-86-462-1111

Outcome results